Garlic powder in the treatment of moderate hyperlipidaemia: A controlled trial and meta-analysis

Journal of the Royal College of Physicians of London

Volumn 30, Issue 4, 1996, Pages 329-334

  Neil, H A W ^a   Silagy, C A ^b   Lancaster, T ^c   Hodgeman, J ^d   Vos, K ^c   Moore, J W ^c   Jones, L ^c   Cahill, J ^e   Fowler, G H ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b FLINDERS UNIVERSITY   (Australia)

^c RADCLIFFE INFIRMARY   (United Kingdom)

^d IMPERIAL COLLEGE LONDON   (United Kingdom)

^e NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALLICIN; APOLIPOPROTEIN A1; APOLIPOPROTEIN B; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; GARLIC; HUMAN; HYPERLIPIDEMIA; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; META ANALYSIS; ORAL DRUG ADMINISTRATION; RANDOMIZED CONTROLLED TRIAL;

ANALYSIS OF VARIANCE; APOLIPOPROTEINS; CHOLESTEROL; DOUBLE-BLIND METHOD; FEMALE; GARLIC; HALITOSIS; HUMANS; HYPERLIPIDEMIAS; MALE; META-ANALYSIS; MIDDLE AGED; PLANTS, MEDICINAL; TRIGLYCERIDES;

EID: 0029790818     PISSN: 00358819     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Neil A, Silagy C. Garlic: its cardio-protective properties. Curr Opin Lipidol 1994;5:6-10.
2. Silagy C, Neil A. Garlic as a lipid lowering agent - a metaanalysis. J Roy Coll Physicians London 1994;28:39-45.
3. Warshafsky S, Kamer RS, Sivak SL. Effect of garlic on total serum cholesterol. A meta-analysis. Ann Intern Med 1993;119:599-605.
4. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972;18:499-502.
5. Easterbrook PJ, Berlin JA, Gopalan R, Matthews DR. Publication bias in clinical research. Lancet 1991;337:867-72.
6. Egger M, Smith GD (editorial). Misleading meta-analysis. Br Med J 1995;310:752-4.
7. Schulz KF, Chalmers I, Hayes RJ, Altman DG. Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA 1995;273:408-12.
8. Simons LA, Balasubramaniam S, Konigsmark MV, Parfitt A, et al. On the effect of garlic on plasma lipids and lipoproteins in mild hypercholesterolaemia. Atherosclerosis 1995;113:219-25.
9. Ramsay LE, Yeo WW, Jackson PR. Dietary reduction of serum cholesterol concentration: time to think again. Br Med J 1991;303:953-7.
10. Neil HAW, Roe L, Godlee RJ, Moore J, et al. Randomised trial of lipid lowering dietary advice in general practice: the effects on serum lipids, lipoproteins, and antioxidants. Br Med J 1995;310:569-73.
11. Tio KK, Yusuf S, Collins R, Held P, Peto R. Effects of intravenous magnesium in suspected acute myocardial infarction: an overview of randomised controlled trials. Br Med J 1991; 303:1499-503.
12. Lau J, Antman EM, Jimenez-Silva J, Kupelnick B, et al. Cumulative meta-analyses of therapeutic trials for myocardial infarction. N Engl J Med 1992;327:248-54.
13. Yusuf S, Koon T, Woods K. Intravenous magnesium in acute myocardial infarction. An effective, safe, and inexpensive intervention. Circulation 1993;87:2043-6.
14. ISIS-4: a randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58,050 patients with suspected acute myocardial infarction. Lancet 1995;345:669-85.
15. West RR. A look at the statistical overview (or meta-analysis). J Roy Coll Physicians London 1993;27:111-5.